CLINICAL_TRIALS
trial_result
· 2019-09-11
Clinical Trial Update: Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) [Phase 2]
Summary
Phase II trial updating nilotinib use in newly diagnosed chronic phase chronic myeloid leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Myelogenous, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2019-09-11